WINDLAS BIOTECH
|
The Current P/S Ratio of WINDLAS BIOTECH is 1.91.
Share Price | ₹549.9 | Apr 25,2024 |
Market Cap | ₹1,143.8 Cr | |
Sales-TTM | ₹600.4 Cr | TTM-Consolidated Results |
Price/Sales | 1.91x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,143.8 Cr] as on Apr 25,2024
(/) Sales [ ₹600.4 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.91x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '1.91 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !
The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH
PS Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 0.38x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2022 at 0.98x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
WINDLAS BIOTECH | 600.4 | 1.91 | 1,143.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.69 | 364,831.0 |
CIPLA LTD | 25,350.2 | 4.48 | 113,471.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.81 | 103,713.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.03 | 95,687.8 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.61 | 101,960.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.66 | 96,093.1 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.70 | 91,124.7 |
LUPIN LTD | 19,480.1 | 3.73 | 72,687.6 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.32 | 64,661.3 |
ABBOTT INDIA LTD | 5,753.4 | 9.48 | 54,533.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.91x |
Max industry PS | 13.61x |
Median industry PS | 5.03x |
Average industry PS | 6.40x |
You may also like the below Video Courses